Safety of Filgotinib in Patients with RA: Laboratory Analysis Results from a Long-Term Extension Study

被引:0
|
作者
Buch, Maya [1 ,2 ]
Galloway, James [3 ]
Favalli, Ennio Giulio [4 ]
Constantin, Arnaud [5 ,6 ]
Durez, Patrick [7 ]
Van Hoek, Paul [8 ]
Watson, Christopher [9 ]
Stiers, Pieter-Jan [8 ]
Rajendran, Vijay [10 ]
Van Beneden, Katrien [8 ]
Takeuchi, Tsutomu [11 ,12 ]
Combe, Bernard [13 ]
机构
[1] Univ Manchester, Manchester, England
[2] NIHR Manchester Biomed Res Ctr, Manchester, England
[3] Kings Coll London, London, England
[4] Univ Milan, ASST Gaetano Pini CTO Inst, Milan, Italy
[5] Toulouse Univ Hosp, Toulouse, France
[6] Univ Toulouse III Paul Sabatier, Toulouse, France
[7] Univ Catholique Louvain UCLouvain, Rheumatol, Clin Univ St Luc, Inst Rech Expt & Clin IREC, Brussels, Belgium
[8] Galapagos NV, Mechelen, Belgium
[9] Galapagos Biotech Ltd, Cambridge, England
[10] Galapagos NV, Ghent, Belgium
[11] Keio Univ, Tokyo, Japan
[12] Saitama Med Univ, Tokyo, Japan
[13] Univ Montpellier, Montpellier, France
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
0280
引用
收藏
页码:535 / 538
页数:4
相关论文
共 50 条
  • [1] SAFETY OF FILGOTINIB IN PATIENTS WITH RA: LABORATORY ANALYSIS RESULTS FROM A LONGTERM EXTENSION STUDY
    Favalli, E. G.
    Buch, M. H.
    Galloway, J.
    Constantin, A.
    Durez, P.
    Van Hoek, P.
    Watson, C.
    Stiers, P. J.
    Rajendran, V.
    Van Beneden, K.
    Takeuchi, T.
    Combe, B.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2023, 82 : 1417 - 1418
  • [2] SAFETY OF FILGOTINIB IN PATIENTS WITH RHEUMATOID ARTHRITIS: ANALYSIS OF LYMPHOCYTES IN THE LONG-TERM EXTENSION FINCH 4 STUDY
    Gottenberg, J. E.
    Burmester, G. R.
    Van Beneden, K.
    Watson, C.
    Seghers, I.
    Rajendran, V.
    Dagna, L.
    Buch, M. H.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2022, 81 : 512 - 513
  • [3] Efficacy of filgotinib in patients with rheumatoid arthritis: Week 156 results from a long-term extension study
    Buch, Maya H.
    Aletaha, Daniel
    Caporali, Roberto
    Combe, Bernard
    Schulze-Koops, Hendrik
    Gottenberg, Jacques-Eric
    Tanaka, Yoshiya
    Blanco, Ricardo
    Takeuchi, Tsutomu
    Omoruyi, Edmund V. Ekoka
    Van Beneden, Katrien
    Rajendran, Vijay
    Watson, Chris
    De Leonardis, Francesco
    Emery, Paul
    [J]. RHEUMATOLOGY, 2024, 63
  • [4] Efficacy of Filgotinib in Patients with Rheumatoid Arthritis: Week 156 Results from a Long-term Extension Study
    Buch, Maya
    Aletaha, Daniel
    Caporali, Roberto F.
    Combe, Bernard G.
    Schulze-Koops, Hendrik
    Gottenberg, Jacques-Eric
    Tanaka, Yoshiya
    Blanco, Ricardo
    Takeuchi, Tsutomu
    Omoruyi, Edmund V. Ekoka
    Van Beneden, Katrien
    Rajendran, Vijay
    Watson, Chris
    De Leonardis, Francesco
    Emery, Paul
    [J]. ARTHRITIS & RHEUMATOLOGY, 2023, 75 : 4229 - 4231
  • [5] EFFICACY OF FILGOTINIB (FIL) IN PATIENTS (PTS) WITH RHEUMATOID ARTHRITIS (RA): WEEK (W) 156 RESULTS FROM A LONG-TERM EXTENSION (LTE) STUDY
    Buch, M. H.
    Aletaha, D.
    Caporali, R.
    Combe, B.
    Schulze-Koops, H.
    Gottenberg, J. E.
    Tanaka, Y.
    Blanco, R.
    Takeuchi, T.
    Omoruyi, E. V. Ekoka
    Van Beneden, K.
    Rajendran, V.
    Watson, C.
    De Leonardis, F.
    Emery, P.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2023, 82 : 729 - 730
  • [6] LONG-TERM SAFETY OF FILGOTINIB IN PATIENTS WITH PSA: WEEK 52 SAFETY DATA FROM A PHASE 2 OPENLABEL EXTENSION STUDY
    Coates, Laura
    Mease, Philip
    Gladman, Dafna
    Van den Bosch, Filip
    Rychlewska-Hanczewska, Anna
    Tasset, Chantal
    Meuleners, Luc
    Trivedi, Mona
    Guo, Ying
    Besuyen, Robin
    Helliwell, Philip
    [J]. RHEUMATOLOGY, 2020, 59
  • [7] SAFETY ANALYSIS OF FILGOTINIB FOR ULCERATIVE COLITIS: RESULTS FROM THE PHASE 2B/3 SELECTION STUDY AND PHASE 3 SELECTIONLTE LONG-TERM EXTENSION STUDY
    Schreiber, Stefan
    Loftus, Edward V.
    Rogler, Gerhard
    Yun, Chohee
    Zhou, Yan
    Zhao, Sally
    Hsieh, Jeremy
    Moerch, Ulrik
    Watanabe, Mamoru
    [J]. GASTROENTEROLOGY, 2021, 160 (06) : S37 - S38
  • [8] Safety analysis of filgotinib for Ulcerative Colitis: Results from the phase 2b/3 SELECTION study and phase 3 SELECTIONLTE long-term extension study
    Schreiber, S. W.
    Watanabe, M.
    Yun, C.
    Zhou, Y.
    Zhao, S.
    Hsieh, J.
    Moerch, U.
    Rogler, G.
    Loftus, E. V., Jr.
    [J]. JOURNAL OF CROHNS & COLITIS, 2021, 15 : S004 - S005
  • [9] Long-term Safety of Filgotinib in Patients with Psoriatic Arthritis, Week 52 Safety Data from a Phase 2 Open-Label Extension Study
    Coates, Laura
    Mease, Philip
    Gladman, Dafna
    Van den Bosch, Filip
    Rychlewska-Hanczewska, Anna
    Tasset, Chantal
    Meuleners, Luc
    Trivedi, Mona
    Gao, Jingjing
    Besuyen, Robin
    Helliwell, Philip
    [J]. ARTHRITIS & RHEUMATOLOGY, 2019, 71
  • [10] Long-Term Safety of Filgotinib in Patients with Psoriatic Arthritis, Week 52 Safety Data from a Phase 2 Open-Label Extension Study
    Gladman, Dafna
    Coates, Laura
    Mease, Philip
    van den Bosch, Filip
    Rychlewska-Hanczewska, Anna
    Tasset, Chantal
    Meuleners, Luc
    Trivedi, Mona
    Guo, Ying
    Besuyen, Robin
    Helliwell, Philip
    [J]. JOURNAL OF RHEUMATOLOGY, 2020, 47 (07) : 1066 - 1067